Developmental Biology

Pregnancy: The extraordinary metabolism of vitamin D

The placenta plays an important role in how vitamin D is metabolized and supplied to the fetus.

Mar 8, 2022

Open access
Copyright information

Download
Cite
CommentOpen annotations (there are currently 0 annotations on this page).
Share

Division of Neonatology, Shawn Jenkins Children’s Hospital, United States
Darby Children’s Research Institute, Medical University of South Carolina, United States

Vitamin D helps the intestine to absorb calcium and other minerals that the body needs, and provides support to the immune system. To carry out these roles, vitamin D must be converted into the active hormone calcitriol (also known as 1,25-dihydroxy-vitamin D). First, vitamin D is metabolized by the liver into a compound called 25(OH)D, which then is broken down into its active form calcitriol, mainly in the kidneys. This metabolic process is tightly regulated and relies on calcium and various hormones, including calcitriol itself (Pike and Christakos, 2017).

In 1979, it was discovered that the level of calcitriol circulating in the blood is elevated during pregnancy (Kumar et al., 1979). This massive increase occurs at the start of pregnancy following the implantation of the placenta (Hollis et al., 2011). However, how and why the metabolism of vitamin D changes so drastically during the early stages of pregnancy is not fully understood.

It was initially assumed that the rising levels of calcitriol were generated in the maternal kidneys, where the key enzyme that metabolizes vitamin D is located (Kumar et al., 1979). However, further studies discovered that this active hormone could also be produced outside the kidneys, bringing into question where this excess of calcitriol is coming from (Gray et al., 1981).

The growing fetus cannot synthesize its own vitamin D, and relies on the placenta to transfer the metabolite 25(OH)D from the maternal bloodstream. This compound was thought to pass into the fetus by passively diffusing across the placenta (Greer et al., 1984; Hollis and Wagner, 2013). Now, in eLife, Jane Cleal from the University of Southampton and co-workers – including Brogan Ashley and Claire Simner as joint first authors – report that the amount of vitamin D the fetus receives is actually regulated by the placenta actively taking up and breaking down 25(OH)D (Ashley et al., 2022).

The team (who are based in various institutes in the United Kingdom and the United States) used two new model systems to study how vitamin D metabolites are regulated in the placenta. First, they built a perfusion model using a structure from the placenta, and flowed it with fluids that mimic how blood circulates from the maternal bloodstream to the fetus. Using this set-up, Ashley, Simner et al. were able to infuse vitamin D metabolites into the bloodstream on the maternal side of the structure, and track the amount that was transferred to the placenta and fetal circulation. In addition to this, the team employed various commonly used techniques to explore the effect vitamin D had on fragments of placenta tissue grown in the laboratory.

These models led to the identification of a mechanism that actively uptakes 25(OH)D on the maternal-facing side of the placenta. Once inside, 25(OH)D is further metabolized to calcitriol, where it imparts impressive alterations on specific placental genes. This influences the level of 25(OH)D and its metabolites in both the fetal and maternal circulation.

These findings suggest that the metabolism of 25(OH)D by the placenta may contribute to the increased level of calcitriol observed in the maternal bloodstream during pregnancy. However, these metabolic changes can only account for a small portion of the excess calcitriol detected. Indeed, a previous study found that a pregnant woman whose kidneys could not metabolize vitamin D only experienced a small increase in calcitriol, despite the placenta and the kidneys of the fetus functioning normally (Greer et al., 1984). This suggests that the placenta only contributes a marginal amount of the calcitriol found in the blood during pregnancy, with the maternal kidneys producing the large majority of the excess.

Further experiments using the model systems revealed that 25(OH)D altered the expression of genes and proteins involved in cellular pathways which are critical for the placenta’s role in pregnancy. This is in keeping with an earlier study which showed a significant association between maternal vitamin D levels and the expression of two placenta proteins linked to pre-eclampsia, a condition that causes vascular changes, high blood pressure and abnormal kidney function during pregnancy (Schulz et al., 2017).

Ashley, Simner et al. also found that vitamin D induced epigenetic changes that reshaped how the placenta responded to this compound and its metabolites. This is similar to a previous study in which vitamin D supplements provided during pregnancy reduced the epigenetic changes associated with gestational aging (Chen et al., 2020).

Vitamin D may be pivotal to the function of the placenta, thereby affecting both maternal and fetal health. As such, the work by Ashley, Simner et al. raises important questions about the role this compound plays during pregnancy. Initially vitamin D was thought to only be involved in maintaining calcium levels; however, this study and others suggest it is also important for modifying the immune response of the fetus (Mirzakhani et al., 2016; Khatiwada et al., 2021; Zahran et al., 2018).

Various other questions about the metabolism of vitamin D also remain unanswered. For example, how are such high amounts of calcitriol tolerated during pregnancy, including by the fetus, which would normally lead to fatal levels of calcium? And how does the enzyme in the maternal kidneys, which is highly regulated, lose control and produce such ‘toxic’ amounts of calcitriol? Investigating these questions, as well as others, will provide new insights into how vitamin D metabolism is controlled during pregnancy and will further our understanding of its role in optimizing maternal and fetal health.

References

1. Ashley B
2. Simner C
3. Manousopoulou A
4. Jenkinson C
5. Hey F
6. Frost JM
7. Rezwan FI
8. White CH
9. Lofthouse E
10. Hyde E
11. Cooke L
12. Barton S
13. Mahon P
14. Curtis EM
15. Moon RJ
16. Crozier SR
17. Inskip HM
18. Godfrey KM
19. Holloway JW
20. Cooper C
21. Jones KS
22. Lewis RM
23. Hewison M
24. Garbis SD
25. Branco MR
26. Harvey NC
27. Cleal JK
(2022) Placental uptake and metabolism of 25(OH)vitamin D determines its activity within the fetoplacental unit
eLife 11:e71094.

https://doi.org/10.7554/eLife.71094
- Google Scholar
1. Chen L
2. Wagner CL
3. Dong Y
4. Wang X
5. Shary JR
6. Huang Y
7. Hollis BW
8. Zhu H
(2020) Effects of maternal vitamin D3 supplementation on offspring epigenetic clock of gestational age at birth: a post-hoc analysis of a randomized controlled trial
Epigenetics 15:830–840.

https://doi.org/10.1080/15592294.2020.1734148
- PubMed
- Google Scholar
1. Gray TK
2. Lowe W
3. Lester GE
(1981) Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D
Endocrine Reviews 2:264–274.

https://doi.org/10.1210/edrv-2-3-264
- PubMed
- Google Scholar
(1984) High concentrations of vitamin D2 in human milk associated with pharmacologic doses of vitamin D2
The Journal of Pediatrics 105:61–64.

https://doi.org/10.1016/s0022-3476(84)80361-3
- PubMed
- Google Scholar
1. Hollis BW
2. Johnson D
3. Hulsey TC
4. Ebeling M
5. Wagner CL
(2011) Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness
Journal of Bone and Mineral Research 26:2341–2357.

https://doi.org/10.1002/jbmr.463
- PubMed
- Google Scholar
1. Hollis BW
2. Wagner CL
(2013) Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes
The Journal of Clinical Endocrinology and Metabolism 98:4619–4628.

https://doi.org/10.1210/jc.2013-2653
- PubMed
- Google Scholar
1. Khatiwada A
2. Wolf BJ
3. Mulligan JK
4. Shary JR
5. Hewison M
6. Baatz JE
7. Newton DA
8. Hawrylowicz C
9. Hollis BW
10. Wagner CL
(2021) Effects of vitamin D supplementation on circulating concentrations of growth factors and immune-mediators in healthy women during pregnancy
Pediatric Research 89:554–562.

https://doi.org/10.1038/s41390-020-0885-7
- PubMed
- Google Scholar
1. Kumar R
2. Cohen WR
3. Silva P
4. Epstein FH
(1979) Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation
The Journal of Clinical Investigation 63:342–344.

https://doi.org/10.1172/JCI109308
- PubMed
- Google Scholar
1. Mirzakhani H
2. Litonjua AA
3. McElrath TF
4. O’Connor G
5. Lee-Parritz A
6. Iverson R
7. Macones G
8. Strunk RC
9. Bacharier LB
10. Zeiger R
11. Hollis BW
12. Handy DE
13. Sharma A
14. Laranjo N
15. Carey V
16. Qiu W
17. Santolini M
18. Liu S
19. Chhabra D
20. Enquobahrie DA
21. Williams MA
22. Loscalzo J
23. Weiss ST
(2016) Early pregnancy vitamin D status and risk of preeclampsia
The Journal of Clinical Investigation 126:4702–4715.

https://doi.org/10.1172/JCI89031
- PubMed
- Google Scholar
1. Pike JW
2. Christakos S
(2017) Biology and mechanisms of action of the vitamin D hormone
Endocrinology and Metabolism Clinics of North America 46:815–843.

https://doi.org/10.1016/j.ecl.2017.07.001
- PubMed
- Google Scholar
1. Schulz EV
2. Cruze L
3. Wei W
4. Gehris J
5. Wagner CL
(2017) Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy
The Journal of Steroid Biochemistry and Molecular Biology 173:273–279.

https://doi.org/10.1016/j.jsbmb.2017.02.003
- PubMed
- Google Scholar
(2018) Significant correlation between regulatory T cells and vitamin D status in term and preterm labor
Journal of Reproductive Immunology 129:15–22.

https://doi.org/10.1016/j.jri.2018.07.004
- PubMed
- Google Scholar

Article and author information

Author details

Carol L Wagner

Carol L Wagner is in the Division of Neonatology, Shawn Jenkins Children’s Hospital and the Darby Children’s Research Institute, Medical University of South Carolina, Charleston, United States

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0003-2764-6533
Bruce W Hollis

Bruce W Hollis is in the Division of Neonatology, Shawn Jenkins Children’s Hospital and the Darby Children’s Research Institute, Medical University of South Carolina, Charleston, United States

For correspondence
hollisb@musc.edu

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0002-2588-5568

Publication history

Version of Record published: March 8, 2022

Copyright

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.